A novel conditional platelet depletion mouse model reveals the importance of platelets in protection against Staphylococcus aureus bacteremia

被引:62
|
作者
Wuescher, L. M. [1 ]
Takashima, A. [1 ]
Worth, R. G. [1 ]
机构
[1] Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, Toledo, OH 43614 USA
关键词
bacteria; blood platelets; sepsis; septic shock; Staphylococcus aureus; SEPTIC SHOCK; THROMBOCYTOPENIA; MEGAKARYOCYTE; INFLAMMATION; PATHOGENESIS; RESPONSES; ABLATION; DEFENSE; SEPSIS; CELLS;
D O I
10.1111/jth.12795
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPlatelets are critical cells for maintaining vascular hemostasis, but their activities in other processes are becoming apparent. Specifically, the ability of platelets to recognize and respond to infectious agents is an important area of investigation. To understand the physiologic roles of platelets invivo, most researchers have used antibody-mediated platelet depletion, which has certain limitations. ObjectiveTo develop an optimal system with which to study the contribution of platelets to protection against S.aureus blood infection. MethodsHere, we describe a novel experimental model of conditional platelet depletion based on the Cre-recombinase cell ablation system. With this technology, the simian diphtheria toxin receptor was expressed in platelet factor4-positive cells (megakaryocytes and platelets). ResultsSystemic administration of diphtheria toxin every 48h resulted in reduced platelet numbers that became undetectable after 6days. Although platelets were depleted, no other blood cells were affected. With this newly developed model, the functional contributions of platelets to protection against Staphylococcus aureus bacteremia was examined. Platelet-depleted mice succumbed to infection more rapidly than wild-type mice, and had a significantly higher bacterial burden in kidneys, elevated levels of serum markers of kidney damage, and increased levels of cytokines indicative of septic shock. ConclusionsHere, we illustrate a new mouse model for conditional platelet depletion, and implicate platelets as important participants in the immune response to bacterial blood infections.
引用
收藏
页码:303 / 313
页数:11
相关论文
共 50 条
  • [1] Characterization of a transgenic mouse model of chronic conditional platelet depletion
    Wuescher, Leah M.
    Nishat, Sharmeen
    Worth, Randall G.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (04) : 704 - 712
  • [2] PROTECTION AGAINST MENINGOCOCCAL COLONIZATION AND BACTEREMIA IN A NEONATAL MOUSE MODEL
    SALIT, IE
    TOMALTY, L
    FRASCH, CE
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1985, 8 (03): : A132 - A132
  • [3] Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model
    Wills, QF
    Kerrigan, C
    Soothill, JS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) : 1220 - 1221
  • [4] Intracellular Activity of Antibiotics against Staphylococcus aureus in a Mouse Peritonitis Model
    Sandberg, Anne
    Hessler, Jonas H. R.
    Skov, Robert L.
    Blom, Jens
    Frimodt-Moller, Niels
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 1874 - 1883
  • [5] Protection against Staphylococcus aureus bacteremia-induced mortality depends on ILC2s and eosinophils
    Krishack, Paulette A.
    Louviere, Tyler J.
    Decker, Trevor S.
    Kuzel, Timothy G.
    Greenberg, Jared A.
    Camacho, Daniel F.
    Hrusch, Cara L.
    Sperling, Anne, I
    Verhoef, Philip A.
    JCI INSIGHT, 2019, 4 (06)
  • [6] Iclaprim activity against wild-type and corresponding thymidine kinase–deficient Staphylococcus aureus in a mouse protection model
    David B. Huang
    Jee Hyun Park
    Timothy M. Murphy
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 409 - 412
  • [7] Novel Structurally Designed Vaccine for S. aureus α-Hemolysin: Protection against Bacteremia and Pneumonia
    Adhikari, Rajan P.
    Karauzum, Hatice
    Sarwar, Jawad
    Abaandou, Laura
    Mahmoudieh, Mahta
    Boroun, Atefeh R.
    Hong Vu
    Tam Nguyen
    Devi, V. Sathya
    Shulenin, Sergey
    Warfield, Kelly L.
    Aman, M. Javad
    PLOS ONE, 2012, 7 (06):
  • [8] INTERACTIONS OF DRUGS ACTING AGAINST STAPHYLOCOCCUS-AUREUS INVITRO AND IN A MOUSE MODEL
    RENNEBERG, J
    KARLSSON, E
    NILSSON, B
    WALDER, M
    JOURNAL OF INFECTION, 1993, 26 (03) : 265 - 277
  • [9] Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis
    Mercier, RC
    Rybak, MJ
    Bayer, AS
    Yeaman, MR
    INFECTION AND IMMUNITY, 2000, 68 (08) : 4699 - 4705
  • [10] Iclaprim activity against wild-type and corresponding thymidine kinase-deficient Staphylococcus aureus in a mouse protection model
    Huang, David B.
    Park, Jee Hyun
    Murphy, Timothy M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (02) : 409 - 412